 |
Clinical Expertise NCGS Laboratories, Inc. (NCGS), founded in 1984, is a full service Contract Research Organization (CRO) focused upon study management, data management, quality assurance and regulatory compliance. Our corporate experience encompasses clinical product development of a diverse group of pharmaceutical, biological, device, botanical and diagnostic products. Our current in-house expertise covers the following therapeutics areas. |
| Psychiatry / CNS | ||||||||
| Indication | PK | QOL | Study Phase | Sites | #Patients | Completion | Intl. | Dom. |
| Chronic Depression Compound (QTC in Healthy Volunteers)* | PK | QOL | I | 6 | 120 | 6 months | X | |
| Attention Deficit Disorder Compound (Serial CSF Trial) | PK | I | 1 | 9 | 3 months | X | ||
| Chronic Depression Compound (Serial CSF Trial) | PK | I | 1 | 36 | 3 months | X | ||
| Schizophrenia | PK | QOL | III Retropective | 4 | 225 | 3 months | X | |
| Schizophrenia | PK | QOL | III Retropsective | 19 | 225 | 2 months | X | |
| Neurology (post neuro-surgery)* | QOL | I/II | 6 | 70 | 1 year | X | ||
| PMS* | QOL | III | 25 | 250 | 2 years | X | Alcoholism (CNS Serial Sampling) | PK | I | 1 | 30 | 6 months | X |
| PK - Pharmacokinetic | QOL - Quality of Life | INTL - International | DOM - Domestic | * - Multiple Disease Indications |